Personalized dosing for hemophilia a: one step closer?
NCT ID NCT05036278
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new scoring method to help doctors choose the best dosing schedule of Jivi (a longer-lasting clotting factor) for people with hemophilia A. 21 participants switched from standard treatments to Jivi, and their dose frequency was based on their personal risk score. The goal was to see if this approach could reduce bleeding while making treatment more convenient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aflac Cancer and Blood Disorders Center - Egleston Hospital
Atlanta, Georgia, 30301, United States
-
Dr. Akshat Jain - Loma Linda University Medical Center
Loma Linda, California, 92354, United States
-
Gulf States Hemophilia & Thrombophilia Center- Texas Medical Center
Houston, Texas, 77030, United States
-
Loma Linda University Children's Hospital - Hematology / Oncology
Loma Linda, California, 92354, United States
-
Luskin Orthopaedic Institute for Children
Los Angeles, California, 90001, United States
-
M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center
Minneapolis, Minnesota, 55455, United States
-
Rush University Medical Center - Oncology
Chicago, Illinois, 60612, United States
-
Rutgers Robert Wood Johnson Medical School - OBGYN
New Brunswick, New Jersey, 08901, United States
-
Stead Family Children's Hospital - Hematology / Oncology
Iowa City, Iowa, 52240, United States
-
UHealth - Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of Colorado | Renal Research Office
Aurora, Colorado, 80045, United States
-
Wellstar MCG Health Medical Center - Gynecology
Augusta, Georgia, 30912, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do newer hemophilia drugs protect joints better? study aims to find out
- Newborn screening study aims to catch rare diseases at birth
- Could home blood tests transform hemophilia care? study seeks patient views
- New clotting factor shows promise for hemophilia a bleeds
- New shot aims to cut bleeding in hemophilia patients
- Bone loss in hemophilia: new study measures the hidden risk